Global Insulin Pump Market Size study & Forecast, by Type (Patch Pumps, Tethered Pumps), by Product Type (Tandem, Accu-Chek, MiniMed, Omnipod, My Life Omnipod, Other Product Types), by Accessories (Insulin reservoir or cartridges, Insulin set insertion de

Global Insulin Pump Market Size study & Forecast, by Type (Patch Pumps, Tethered Pumps), by Product Type (Tandem, Accu-Chek, MiniMed, Omnipod, My Life Omnipod, Other Product Types), by Accessories (Insulin reservoir or cartridges, Insulin set insertion devices, Battery), by End-User (Homecare, Hospitals & clinics, Laboratories) and Regional Analysis, 2023-2030

Global Insulin Pump Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. An insulin pump is a medical device used to administer insulin to individuals with diabetes. It is an alternative to traditional insulin injections and provides continuous and customizable delivery of insulin throughout the day. The pump consists of a small device that holds insulin and is typically worn on the outside of the body, either attached to a belt or placed in a pocket. The key factors such as rising prevalence of diabetes, growing awareness about insulin pumps, and recent product approvals, innovation and development are anticipated to create a lucrative demand for the market during forecast period.

Moreover, the global prevalence of diabetes has been steadily increasing over the years. This rise is primarily attributed to factors such as sedentary lifestyles, unhealthy dietary habits, and obesity. As the number of individuals diagnosed with diabetes continues to grow, so does the potential customer base for insulin pump manufacturers. The IDF Diabetes Atlas estimates that 537 million persons between the ages of 20 and 79 will have diabetes in 2021. Additionally, it is anticipated that there would be 643 million patients worldwide by 2030 and 783 million by 2045. Additionally, rising technological advancement in insulin pumps is anticipated to create lucrative opportunities for the market. However, the high cost of insulin pumps stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Insulin Pump Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to the existence of significant insulin pump players. Additionally, it is anticipated that the market in the area would be driven by the rising incidence of obesity, high medical costs, technological advancements, and new releases. Asia Pacific is expected to grow significantly during the forecast period, factors such as growing healthcare funding and government programs to raise diabetes awareness, and rising prevalence of diabetes are key drivers of growth in the region.

Major market players included in this report are:
Medtronic (Ireland)
Tandem Diabetes Care, Inc. (U.S.)
Ypsomed AG (Switzerland)
Insulet Corporation (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
CeQur Simplicity (Switzerland)
Microtec Medical Ltd (U.K.)
ViCentra B.V. (Netherlands)
SOOIL Developments Co., Ltd (Korea)
EOFLOW CO., LTD. (Korea)
Recent Developments in the Market:
 In Jan. 2023, AMF Medical SA, a privately held Swiss developer of the Sigi patch pump, was acquired by Tandem Diabetes Care, Inc.. The Sigi patch pump is a rechargeable device that makes utilizing pre-filled insulin cartridges for managing diabetes easily.

Global Insulin Pump Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Type, Product Type, Accessories, End-User, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Patch Pumps
Tethered Pumps
By Product Type:
Tandem
Accu-Chek
MiniMed
Omnipod
My Life Omnipod
Other Product Types
By Accessories:
Insulin reservoir or cartridges
Insulin set insertion devices
Battery
By End-User:
Homecare
Hospitals & clinics
Laboratories

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Companies Mentioned
Medtronic (Ireland)
Tandem Diabetes Care, Inc. (U.S.)
Ypsomed AG (Switzerland)
Insulet Corporation (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
CeQur Simplicity (Switzerland)
Microtec Medical Ltd (U.K.)
ViCentra B.V. (Netherlands)
SOOIL Developments Co., Ltd (Korea)
EOFLOW CO., LTD. (Korea)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.